| Authors: |
Mai EK; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany., Goldschmid H; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany; National Centre for Tumour Diseases Heidelberg, Heidelberg, Germany. Electronic address: hartmut.goldschmidt@med.uni-heidelberg.de., Miah K; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Bertsch U; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany; National Centre for Tumour Diseases Heidelberg, Heidelberg, Germany., Besemer B; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Hänel M; Department of Internal Medicine III, Clinic Chemnitz, Chemnitz, Germany., Krzykalla J; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Fenk R; Department of Haematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Schlenzka J; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany., Munder M; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany., Dürig J; Department for Haematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany., Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany., Huhn S; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany., Hose D; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany., Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany., Kunz C; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Mann C; Department of Haematology, Oncology and Immunology, Philipps-University Marburg, Marburg, Germany., Weinhold N; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany., Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Schroers R; Medical Clinic, University Hospital Bochum, Bochum, Germany., von Metzler I; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany., Schieferdecker A; Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Thomalla J; Haematology-Oncology Centre, Koblenz, Germany., Reimer P; Clinic for Haematology, Oncology and Stem Cell Transplantation, Evangelische Kliniken Essen-Mitte, Essen, Germany., Mahlberg R; Internal Medicine I, Hospital Mutterhaus der Borromäerinnen, Trier, Germany., Graeven U; Medical Clinic I, Hospital Maria Hilf, Mönchengladbach, Germany., Kremers S; Haematology-Oncology Centre, Lebach, Germany., Martens UM; Haematology, Oncology, Palliative Care, SLK Clinic Heilbronn, Heilbronn, Germany., Kunz C; Haematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany., Hensel M; Mannheimer Onkologie Praxis, Mannheim, Germany., Benner A; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Seidel-Glätzer A; Coordination Centre for Clinical Trials Heidelberg, Heidelberg, Germany., Weisel KC; Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Raab MS; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany., Salwender HJ; Asklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona and St Georg, Hamburg, Germany. |
